Amarillo Biosciences
OverviewSuggest Edit
Amarillo Biosciences is a specialty biopharmaceutical company working in Phase 2 human clinical trials with a well-characterized therapeutic agent, interferon-alpha, in a proprietary low-dose oral formulation.
| Type | Public | |
| HQ | Amarillo, US | Map |
| Website | amarbio.com | |
| Employee Ratings | More |
Latest Updates
| Employees (est.) (Feb 2019) | 3 | |
| Revenue (FY, 2018) | $77.7 K | (-69%) |
Amarillo Biosciences Office Locations
Amarillo Biosciences Financials and Metrics
Amarillo Biosciences Revenue
| USD | |
|---|---|
Revenue (Q1, 2019) | 4.1k |
Gross profit (Q1, 2019) | 1.4k |
Gross profit margin (Q1, 2019), % | 33.3% |
Net income (Q1, 2019) | (391.4k) |
EBIT (Q1, 2019) | (390.5k) |
Cash (31-Mar-2019) | 1.0m |
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.4k | 250.5k | 56.6k | 250.0 | 14.9k | 4.1k | ||||||||||
Cost of goods sold | 5.1k | 58.8k | 43.3k | 707.0 | 16.8k | 2.7k | ||||||||||
Gross profit | (700.0) | 191.7k | 13.3k | (457.0) | (1.9k) | 1.4k | ||||||||||
Gross profit Margin, % | (16%) | 77% | 23% | (183%) | (13%) | 33% |
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 9.1k | 3.8k | 1.5k | 279.0 | 100.1k | 217.9k | 264.2k | 312.3k | 176.4k | 53.0k | 69.4k | 145.0k | 1.7m | 1.4m | 1.1m | 1.0m |
Accounts Receivable | 2.2k | 6.7k | ||||||||||||||
Inventories | 9.0k | |||||||||||||||
Current Assets | 43.0k | 26.1k | 52.2k | 34.5k | 151.3k | 252.6k | 266.2k | 453.8k | 281.5k | 152.3k | 156.8k | 212.3k | 1.7m | 1.5m | 1.2m | 1.1m |
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (102.8k) | (114.1k) | (121.6k) | (136.2k) | (179.3k) | (189.0k) | ||||||||||
Cash From Operating Activities | (474.9k) | (110.7k) | (183.7k) | (260.3k) | (207.4k) | (89.1k) | 1.7k | (325.1k) | (427.0k) | (126.5k) | (216.2k) | |||||
Cash From Investing Activities | (14.1k) | (19.0) | (7.8k) | (7.8k) | (11.1k) | (11.6k) | (8.6k) | (68.1k) | (102.2k) | (5.3k) | (25.8k) | (39.9k) | (1.7k) | (2.1k) | 55.6k | (1.6k) |
Cash From Financing Activities | 490.8k | 108.0k | 186.5k | 261.9k | 261.9k | 250.0k | 684.4k | 684.4k | 50.6k | 120.6k | 239.4k | (195.0k) | (195.0k) | (195.0k) | (12.5k) |
| USD | Y, 2019 |
|---|---|
Revenue/Employee | 1.4k |
Financial Leverage | 2.2 x |
Amarillo Biosciences News and Updates
Amarillo Biosciences First-Half 2018 Business Update
Amarillo Biosciences Frequently Asked Questions
How many employees does Amarillo Biosciences have?
Amarillo Biosciences has 3 employees.
What is Amarillo Biosciences revenue?
Latest Amarillo Biosciences annual revenue is $77.7 k.
What is Amarillo Biosciences revenue per employee?
Latest Amarillo Biosciences revenue per employee is $25.9 k.
Who are Amarillo Biosciences competitors?
Competitors of Amarillo Biosciences include Obsidian Therapeutics, Z Factor and Mymetics.
Where is Amarillo Biosciences headquarters?
Amarillo Biosciences headquarters is located at 4134 Business Park Dr, Amarillo.
Where are Amarillo Biosciences offices?
Amarillo Biosciences has an office in Amarillo.
How many offices does Amarillo Biosciences have?
Amarillo Biosciences has 1 office.